Who Paid My Doc
M19-044 Rinvoq Phase 3 Vitiligo
ClinicalTrials.gov NCT06118411
Research payments
$169,075
Through program year 2024, $169,075 in research payments was reported against M19-044 Rinvoq Phase 3 Vitiligo, across 49 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT06118411
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2024 | Research | $169,075 | 49 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Gabriela Cobos Boston, MA Named on 1 payment
- David Rosmarin Indianapolis, IN Named on 1 payment
- Eli Saleeby Coral Springs, FL Named on 1 payment
- Victor Huang Sacramento, CA Named on 1 payment
- Jessica Shiu Irvine, CA Named on 1 payment
- Robert Nossa Marstons Mills, MA Named on 1 payment
- Samuel Sanchez Caguas, PR Named on 1 payment
- Sandro Bacchelli Hollywood, FL Named on 1 payment
- Eduardo Weiss Hollywood, FL Named on 1 payment
- Navid Ezra Thousand Oaks, CA Named on 1 payment
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.